Piergiorgio Lochner1, Cornelia Mader1, Raffaele Nardone2, Frediano Tezzon1, Maria Luisa Zedde3, Giovanni Malferrari3, Francesco Brigo4. 1. Department of Neurology, Franz Tappeiner Hospital, Rossini Street 5, 39012 Merano, BZ Italy. 2. Department of Neurology, Franz Tappeiner Hospital, Rossini Street 5, 39012 Merano, BZ Italy ; Department of Neurology, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria. 3. Neurology Department, Arcispedale S. Maria Nuova, Reggio, Italy. 4. Department of Neurology, Franz Tappeiner Hospital, Rossini Street 5, 39012 Merano, BZ Italy ; Section of Clinical Neurology, Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
Abstract
PURPOSE: To evaluate the feasibility and utility of serial measuring of the optic nerve sheath diameter beyond the hyperacute and acute stage of intracerebral hemorrhage (ICH). METHODS: Four patients with extensive ICH in the left basal ganglia were followed using ultrasound (US) and cerebral CT scans. RESULTS: Optic nerve sheath diameter values assessed beyond the acute stage of ICH showed a high correlation (ρ = 0.84, p = 0.0022) with midline shift of the third ventricle seen on CT scans. CONCLUSIONS: Optic nerve sonography can be useful to evaluate patients with extensive ICH beyond the acute stage and help monitoring clinical evolution in these patients, when ICP monitoring is not feasible.
PURPOSE: To evaluate the feasibility and utility of serial measuring of the optic nerve sheath diameter beyond the hyperacute and acute stage of intracerebral hemorrhage (ICH). METHODS: Four patients with extensive ICH in the left basal ganglia were followed using ultrasound (US) and cerebral CT scans. RESULTS: Optic nerve sheath diameter values assessed beyond the acute stage of ICH showed a high correlation (ρ = 0.84, p = 0.0022) with midline shift of the third ventricle seen on CT scans. CONCLUSIONS: Optic nerve sonography can be useful to evaluate patients with extensive ICH beyond the acute stage and help monitoring clinical evolution in these patients, when ICP monitoring is not feasible.
Authors: David Skoloudík; Roman Herzig; Tána Fadrná; Michal Bar; Pavel Hradílek; Martin Roubec; Monika Jelínková; Daniel Sanák; Michal Král; Jana Chmelová; Miroslav Herman; Katerina Langová; Petr Kanovsky Journal: Br J Ophthalmol Date: 2010-08-01 Impact factor: 4.638